Study guide

4.2 Mental Health Disorders, Substance Use & Sleep

Certification in Clinical Sleep Health CCSH

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Sleep Physiology

1.1 CCSH Exam Overview & Clinical Scope 1.2 Sleep Architecture, Stages & Normal Cycles 1.3 Neurobiology & The Two-Process Model of Sleep

2 Chapter 2: Circadian Biology, Lifespan & Normal Variation

2.1 Circadian Biology & Melatonin Regulation 2.2 Sleep Across the Lifespan: Pediatric to Geriatric 2.3 Sex, Gender, Environment & Culture: Variations in Normal Sleep

3 Chapter 3: Abnormal Sleep: Classification, Prevalence & Consequences

3.1 Classification, Terminology, Prevalence & Acute vs. Chronic Sleep Disturbances 3.2 Short- and Long-Term Effects of Sleep Disruption, Deprivation & Restriction

4 Chapter 4: Comorbid Medical & Mental Health Conditions

4.1 Cardiopulmonary, Metabolic & Neurological Comorbidities 4.2 Mental Health Disorders, Substance Use & Sleep 4.3 Chronic Pain & Other Medical Conditions Affecting Sleep

5 Chapter 5: Clinical Assessment, Documentation & Medications

5.1 Validated Questionnaires & Screening Instruments 5.2 Comprehensive Sleep History & Physical Assessment 5.3 Quality of Life, Health Changes & Clinical Documentation 5.4 Medications, OTC Products, Supplements & Substances: Effects on Sleep

6 Chapter 6: Sleep Testing & Explaining Results

6.1 Diagnostic Sleep Testing Modalities 6.2 Split-Night and Titration Studies, PAP-NAP, Oximetry & Explaining Results

7 Chapter 7: Sleep-Related Breathing Disorders

7.1 Obstructive Sleep Apnea: Pathophysiology & Diagnosis 7.2 Central Sleep Apnea, Cheyne-Stokes & Emergent Apneas 7.3 Sleep-Related Hypoventilation & Obesity Hypoventilation Syndrome

8 Chapter 8: Positive Airway Pressure Therapy & Titration

8.1 Modes of PAP Therapy: CPAP, APAP, BiPAP & ASV 8.2 Interfaces, Humidification & Equipment Troubleshooting 8.3 Objective PAP Adherence Monitoring & Troubleshooting

9 Chapter 9: Non-PAP Treatments for Sleep Apnea

9.1 Oral Appliance Therapy: Indications, Candidacy & Side Effects 9.2 Surgical Interventions & Hypoglossal Nerve Stimulation 9.3 Positional Therapy & Lifestyle Modifications

10 Chapter 10: Insomnia & Circadian Rhythm Sleep-Wake Disorders

10.1 Chronic Insomnia: ICSD-3 Classification & Assessment 10.2 Cognitive Behavioral Therapy for Insomnia (CBT-I) Principles 10.3 Circadian Rhythm Sleep-Wake Disorders & Light Therapy

11 Chapter 11: Hypersomnias, Parasomnias & Movement Disorders

11.1 Central Disorders of Hypersomnolence 11.2 Parasomnias: NREM & REM Sleep Behavior Disorders 11.3 Sleep-Related Movement Disorders: RLS & PLMD

12 Chapter 12: Patient, Family & Community Education

12.1 Health Literacy, Plain Language & Teach-Back 12.2 Cultural Competency, Diversity of the Learner & Language Access 12.3 Readiness to Learn & Teaching Across Age, Development and Role 12.4 Learning Styles, Adult Learning Principles & Teaching Methods 12.5 Communication Barriers, Disabilities & Educating Families, Professionals and the Community

13 Chapter 13: Self-Management & Behavior Change

13.1 Motivational Interviewing & Overcoming Treatment Barriers 13.2 Sleep Hygiene Education Across Lifestyles and Settings 13.3 Self-Assessment & Self-Management Tools 13.4 Commercial Drivers, Transportation Regulations & Drowsy Driving

14 Chapter 14: Care Coordination, Guidelines, Telehealth & Ethics

14.1 Interdisciplinary Care Coordination & Patient Navigation 14.2 Chronic Disease Model, Care Plans & AASM Clinical Practice Guidelines 14.3 Telehealth Modalities & Remote Patient Monitoring 14.4 Ethics, Scope of Practice & Legal Standards

15 Chapter 15: Program Administration, Public Health & Safety

15.1 Building Collaborative Sleep Programs: Perioperative, Occupational, Outpatient & Support Models 15.2 Quality Improvement, Clinical Outcomes & Accreditation Standards 15.3 Sleep as a Public Health Issue: Community Outreach & Public Policy 15.4 Clinical Safety, Infection Control & Emergency Protocols

4.2 Mental Health Disorders, Substance Use & Sleep

Key Takeaways Explain This Topic AI

Insomnia roughly doubles the risk of developing depression, and treating insomnia with CBT-I improves both sleep and mood.

Reduced need for sleep can signal a manic episode, and sleep loss can trigger mania in bipolar disorder.

Nightmares affect most people with PTSD; image rehearsal therapy is recommended, and OSA is common in veterans with PTSD.

Alcohol shortens sleep latency but suppresses REM early, fragments the second half of the night and worsens OSA; the AASM advises against cannabis for OSA.

Opioids cause central apnea and hypoventilation, and combining them with benzodiazepines carries an FDA boxed warning for respiratory depression.

Last updated: October 2026

4.2 Mental Health Disorders, Substance Use & Sleep

The blueprint names mental health disorders (depression, anxiety, substance abuse) among the conditions the CCSH must link to abnormal sleep (Domain 1, Task C). These relationships run in both directions: poor sleep increases the risk and severity of mental-health problems, and mental-health conditions and substances disrupt sleep.

Depression

Insomnia is reported by most people with major depression, and about 15–20% have hypersomnia , more often younger people and those with atypical features.

Insomnia is also a risk factor : a meta-analysis found that people with insomnia had about twice the risk of developing depression.

Polysomnography in depression often shows short REM latency , increased REM density and reduced slow-wave sleep, along with early morning awakening.

Insomnia and nightmares are independent risk factors for suicidal thoughts and behavior .

CBT-I improves sleep in people with depression and can improve depressive symptoms too, so a comorbid diagnosis is not a reason to withhold it.

Bipolar Disorder

A decreased need for sleep (feeling rested after 3 hours) is a classic early sign of mania, and sleep loss from travel, shift work or a newborn can trigger an episode. Regular sleep-wake routines are part of treatment. Sleep restriction therapy for insomnia needs close coordination with the mental-health team.

Anxiety Disorders

Generalized anxiety causes prolonged sleep latency and worry at bedtime. Nocturnal panic attacks arise from NREM sleep (often the transition into deeper sleep) and wake the person with fear, racing heart and shortness of breath, with full alertness and recall. They must be distinguished from sleep terrors (no recall), OSA choking arousals and nocturnal reflux.

Post-Traumatic Stress Disorder (PTSD)

Trauma-related nightmares and insomnia are core features; most people with PTSD report nightmares.

Image rehearsal therapy (IRT) is recommended for nightmare disorder. Prazosin has been used for PTSD-related nightmares, but a large 2018 Veterans Affairs trial found no benefit over placebo, so evidence is mixed.

OSA is common in veterans with PTSD, and PAP adherence can be harder because masks may trigger trauma memories; gradual desensitization and trauma-informed care help.

Psychotic Disorders and ADHD

Schizophrenia: circadian disruption and insomnia are common; many antipsychotics cause sedation and weight gain (raising OSA risk) or restlessness that can mimic RLS.

ADHD: overlaps with RLS, periodic limb movements, OSA in children and delayed sleep phase. Stimulant medications can cause insomnia if taken late.

Screening and the CCSH's Role

  • Tool What it screens Common cutoffs
  • PHQ-9 Depression severity 5, 10, 15, 20 = mild, moderate, moderately severe, severe
  • GAD-7 Anxiety severity 5, 10, 15 = mild, moderate, severe

PHQ-9 item 9 Thoughts of death or self-harm Any positive answer needs same-day follow-up under the clinic's safety protocol

The CCSH screens, documents and coordinates with mental-health providers , but does not diagnose psychiatric disorders. Any statement of suicidal intent requires immediate action according to the organization's protocol, such as staying with the patient, notifying the provider and connecting to crisis services (in the U.S., the 988 Suicide & Crisis Lifeline ).

Substance Use and Sleep

Substance Effects on sleep Teaching points

Alcohol Falls asleep faster, but REM is suppressed early and sleep is fragmented later as alcohol is metabolized; relaxes airway muscles and worsens OSA; insomnia during withdrawal can last for months and raises relapse risk Avoid alcohol for several hours before bed; never mix with sedatives

Caffeine Blocks adenosine receptors; half-life about 5 hours (wide range); delays sleep and lightens it Avoid within about 6 hours of bedtime; watch energy drinks

Nicotine Stimulant; smokers report more insomnia, and nighttime withdrawal causes awakenings; nicotine patches can cause vivid dreams Offer cessation resources; adjust patch timing with the prescriber

Cannabis May shorten sleep latency at first, but tolerance develops; withdrawal causes insomnia and vivid dreams The AASM's 2018 position statement says medical cannabis and its extracts should not be used to treat OSA

Opioids Cause central sleep apnea, ataxic breathing and hypoventilation; worsen OSA Report new or increased opioids to the sleep physician; the FDA requires a boxed warning when opioids are combined with benzodiazepines

Stimulants (cocaine, methamphetamine, misused prescriptions) Severe insomnia during use; long sleep and sleepiness during withdrawal Screen without judgment; coordinate addiction care

Sedative-hypnotics (misuse or withdrawal) Rebound insomnia; benzodiazepine withdrawal can cause seizures Tapering is directed by the prescriber

Patients with substance use disorders often use alcohol or cannabis to "self-treat" insomnia. CBT-I adapted for recovery settings is effective and supports relapse prevention.

Important

Medication-assisted treatment for opioid use disorder (methadone or buprenorphine) is lifesaving and should not be stopped because of sleep apnea. Instead, the sleep team evaluates and treats any central or obstructive apnea while coordinating with the addiction provider.

Case Walkthrough: Trauma-Informed PAP Care

A 41-year-old veteran with PTSD and severe OSA stops CPAP after two nights, saying the mask "feels like being smothered" and brings back combat memories.

Validate and assess safety: thank him for sharing, ask about nightmares, mood and any thoughts of self-harm, and follow the clinic's safety protocol if needed.

Give control: let him choose the interface (nasal pillows often feel least confining), when sessions happen and when to stop a practice session.

Desensitize gradually: hold the mask by hand while awake, then headgear, then low pressure, then naps, as described in the troubleshooting section.

Coordinate care: with permission, involve his mental-health clinician so that imagery rehearsal, CBT-I and trauma treatment support PAP use.

Follow up early: check downloads within days and celebrate small gains.

Trauma-informed care rests on safety, trust, choice, collaboration and empowerment. These principles help any patient whose distress is triggered by equipment or by the setting of a sleep study.

Quick Reference: Substance Effects on Sleep Testing

  • Substance Effect on PSG or MSLT
  • Recent alcohol Worsens apnea; suppresses early REM
  • Stopping an SSRI shortly before testing Rebound REM can create SOREMPs
  • Cannabis use or withdrawal Changes REM and sleep latency; may be detected on drug screens
  • Stimulants Prolong sleep latency; withdrawal shortens it